Patents by Inventor Eric R. Weber

Eric R. Weber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant pokeweed antiviral proteins, compositions and methods related thereto
    Patent number: 9023596
    Abstract: The present invention provides novel, modified pokeweed antiviral proteins, nucleic acids that encode the proteins, conjugates that incorporate the proteins, and methods to make and use the proteins. The present invention also provides methods to administer the conjugates to animals, for the purpose of directing toxin to particular cells.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: May 5, 2015
    Assignees: Colorado State University Research Foundation, Cedus, Inc.
    Inventors: Eric R. Weber, Torrance M. Nett
  • Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto
    Publication number: 20140094592
    Abstract: The present invention provides novel, modified pokeweed antiviral proteins, nucleic acids that encode the proteins, conjugates that incorporate the proteins, and methods to make and use the proteins. The present invention also provides methods to administer the conjugates to animals, for the purpose of directing toxin to particular cells.
    Type: Application
    Filed: October 3, 2013
    Publication date: April 3, 2014
    Applicants: COLORADO STATE UNIVERSITY RESEARCH FOUNDATION, CEDUS, INC.
    Inventors: Eric R. Weber, Torrance M. Nett
  • Recombinant pokeweed antiviral proteins, compositions and methods related thereto
    Patent number: 8575109
    Abstract: The present invention provides novel, modified pokeweed antiviral proteins, nucleic acids that encode the proteins, conjugates that incorporate the proteins, and methods to make and use the proteins. The present invention also provides methods to administer the conjugates to animals, for the purpose of directing toxin to particular cells.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: November 5, 2013
    Assignees: Cedus, Inc., Colorado State University Research Foundation
    Inventors: Eric R. Weber, Torrance M. Nett
  • Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto
    Publication number: 20110281299
    Abstract: The present invention provides novel, modified pokeweed antiviral proteins, nucleic acids that encode the proteins, conjugates that incorporate the proteins, and methods to make and use the proteins. The present invention also provides methods to administer the conjugates to animals, for the purpose of directing toxin to particular cells.
    Type: Application
    Filed: July 15, 2009
    Publication date: November 17, 2011
    Applicants: COLORADO STATE UNIVERSITY RESEARCH FOUNDATION, CEDUS, INC.
    Inventors: Eric R. Weber, Torrance M. Nett
  • Dermatophagoides nucleic acid molecules
    Patent number: 7589187
    Abstract: The present invention relates to high molecular weight Dermatophagoides proteins, nucleic acid molecules encoding such proteins, and therapeutic and diagnostic reagents derived from such proteins.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: September 15, 2009
    Assignee: Heska Corporation
    Inventors: Catherine A. McCall, Shirley Wu Hunter, Eric R. Weber
  • CANINE AND FELINE IMMUNOREGULATORY PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF
    Publication number: 20090111970
    Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
    Type: Application
    Filed: September 19, 2008
    Publication date: April 30, 2009
    Inventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
  • Canine IL-5 proteins and fragments thereof
    Patent number: 7427661
    Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: September 23, 2008
    Assignee: Heska Corporation
    Inventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
  • Dermatophagoides proteins and uses thereof
    Patent number: 7256263
    Abstract: The present invention relates to high molecular weight Dermatophagoides proteins, nucleic acid molecules encoding such proteins, and therapeutic and diagnostic reagents derived from such proteins.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: August 14, 2007
    Assignee: Heska Corporation
    Inventors: Catherine A. McCall, Shirley Wu Hunter, Eric R. Weber
  • Equine Fc epsilon receptor alpha protein
    Patent number: 7226996
    Abstract: The present invention relates to equine Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: June 5, 2007
    Assignee: Heska Corporation
    Inventors: Eric R. Weber, Catherine A. McCall
  • Cannie IL-5 nucleic acid molecules
    Patent number: 7183080
    Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
    Type: Grant
    Filed: February 24, 2004
    Date of Patent: February 27, 2007
    Assignee: Heska Corporation
    Inventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
  • Dermatophagoides proteins and fragments thereof
    Patent number: 7128921
    Abstract: The present invention relates to high molecular weight Dermatophagoides proteins, nucleic acid molecules encoding such proteins, and therapeutic and diagnostic reagents derived from such proteins.
    Type: Grant
    Filed: September 14, 2000
    Date of Patent: October 31, 2006
    Assignee: Heska Corporation
    Inventors: Catherine A. McCall, Shirley Wu Hunter, Eric R. Weber
  • Anti-equine Fc epsilon receptor alpha chain antibodies and methods to detect IgE
    Patent number: 6887672
    Abstract: The present invention relates to equine Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Grant
    Filed: May 8, 2003
    Date of Patent: May 3, 2005
    Assignee: Heska Corporation
    Inventors: Eric R. Weber, Catherine A. McCall
  • Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
    Publication number: 20040191868
    Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.
    Type: Application
    Filed: February 24, 2004
    Publication date: September 30, 2004
    Applicant: Heska Corporation
    Inventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
  • Anti-equine Fc epsilon receptor alpha chain antibodies and method to detect IgE
    Publication number: 20030235579
    Abstract: The present invention relates to equine Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Application
    Filed: May 8, 2003
    Publication date: December 25, 2003
    Inventors: Eric R. Weber, Catherine A. McCall
  • Equine Fc epsilon receptor alpha chain proteins and uses thereof
    Patent number: 6582701
    Abstract: The present invention relates to equine Fc epsilon receptor alpha chain nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins, and inhibitors of such proteins. The present invention also includes methods to detect IgE using such proteins and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to mediate Fc epsilon receptor-mediated biological responses.
    Type: Grant
    Filed: February 29, 2000
    Date of Patent: June 24, 2003
    Assignee: Heska Corporation
    Inventors: Eric R. Weber, Catherine A. McCall
  • Ectoparasite saliva proteins and apparatus to collect such proteins
    Patent number: 6576238
    Abstract: The present invention is directed to a novel product and method for isolating ectoparasite saliva proteins, and a novel product and method for detecting and/or treating allergic dermatitis in an animal. The present invention also relates to ectoparasite saliva proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to obtain such proteins and to use such proteins to identify animals susceptible to or having allergic dermatitis. The present invention also includes therapeutic compositions comprising such proteins and their use to treat animals susceptible to or having allergic dermatitis.
    Type: Grant
    Filed: August 27, 1998
    Date of Patent: June 10, 2003
    Assignee: Heska Corporation
    Inventors: Eric R. Weber, Shirley Wu Hunter, Glenn Robert Frank, Lynda Wallenfels
  • NOVEL DERMATOPHAGOIDES PROTEINS AND USES THEREOF
    Publication number: 20030096779
    Abstract: The present invention relates to high molecular weight Dermatophagoides proteins, nucleic acid molecules encoding such proteins, and therapeutic and diagnostic reagents derived from such proteins.
    Type: Application
    Filed: August 13, 2002
    Publication date: May 22, 2003
    Inventors: Catherine A. McCall, Shirley Wu Hunter, Eric R. Weber
  • Ectoparasite saliva proteins and apparatus to collect such proteins
    Patent number: 6485968
    Abstract: The present invention is directed to a novel product and method for isolating ectoparasite saliva proteins, and a novel product and method for detecting and/or treating allergic dermatitis in an animal. The present invention also relates to ectoparasite saliva proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to obtain such proteins and to use such proteins to identify animals susceptible to or having allergic dermatitis. The present invention also includes therapeutic compositions comprising such proteins and their use to treat animals susceptible to or having allergic dermatitis.
    Type: Grant
    Filed: January 8, 1998
    Date of Patent: November 26, 2002
    Assignee: Heska Corporation
    Inventors: Eric R. Weber, Shirley Wu Hunter, Gek-Kee Sim, Glenn Robert Frank, Lynda Wallenfels
  • Novel ectoparasite salvia proteins and apparatus to collect such proteins
    Publication number: 20020142352
    Abstract: The present invention is directed to a novel product and method for isolating ectoparasite saliva proteins, and a novel product and method for detecting and/or treating allergic dermatitis in an animal. The present invention also relates to ectoparasite saliva proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to obtain such proteins and to use such proteins to identify animals susceptible to or having allergic dermatitis. The present invention also includes therapeutic compositions comprising such proteins and their use to treat animals susceptible to or having allergic dermatitis.
    Type: Application
    Filed: February 7, 2002
    Publication date: October 3, 2002
    Applicant: HESKA CORPORATION
    Inventors: Shirley Wu Hunter, Gek-Kee Sim, Eric R. Weber
  • Dermatophagoides nucleic acid molecules, proteins and uses thereof
    Patent number: 6455686
    Abstract: The present invention relates to high molecular weight Dermatophagoides proteins, nucleic acid molecules encoding such proteins, and therapeutic and diagnostic reagents derived from such proteins.
    Type: Grant
    Filed: April 15, 1999
    Date of Patent: September 24, 2002
    Assignee: Heska Corporation
    Inventors: Catherine A. McCall, Shirley Wu Hunter, Eric R. Weber